The molecular underpinnings of prostate cancer: impacts on management and pathology practice
Daniel Nava Rodrigues(Institute of Cancer Research), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Semini Sumanasuriya(Institute of Cancer Research), George Seed(Institute of Cancer Research), Gunther Boysen, Angelo M. De Marzo(Johns Hopkins University)
Cited by 43
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k